pioglitazone  - Drug Details
📊 Estimates pioglitazone  Dialyzability By Different_Modalities

pioglitazone 

Complete Drug Information

Drug Name
pioglitazone 
Trade Names
Actos
Pregnancy Category
AU: B3
Routes of Administration
Oral
Protein Binding
>99%%
Metabolism
Liver (CYP2C8)
Elimination
3–7 hours
Excretion
Bile duct
Formula
C19H20N2O3S
Molar Mass
356.44
Melting Point
183 to 184 °C
Drug Class
Thiazolidinedione
Volume of Distribution
0.25 L/kg

🤰 Pregnancy Category Information

Category: AU: B3

Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human fetus. Animal studies have shown evidence of an increased occurrence of fetal damage, the significance of which is considered uncertain in humans.